Pharmaceutical Services | Home Page

News

- 20/09/2023 EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna

- 20/09/2023 Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5

- 31/08/2023 Comirnaty: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5

- 17/02/2023 CHESSMEN, the Joint Action to mitigate medicine’s shortages

- 01/02/2023 Quick Guide on CTR

- 24/11/2022 EMA recommends approval of VidPrevtyn Beta as a COVID-19 booster vaccine

- 23/11/2022 EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders

- 02/11/2022 EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age

- 02/11/2022 EMA recommends approval of second adapted Spikevax vaccine

- 02/11/2022 EMA recommends measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders